Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$899.11M+20.7%$868.45M+21.5%$825.94M+21.1%$772.53M+17.7%$744.85M+20.6%
$210.86M+30.7%$198.34M+26.5%$184.21M+26.6%$167.33M+23.9%$161.33M+26.1%
$688.25M+17.9%$670.11M+20.1%$641.74M+19.7%$605.19M+16.2%$583.53M+19.2%
76.5%-1.8pp77.2%-0.9pp77.7%-1.0pp78.3%-1.1pp78.3%-0.9pp
$224.44M+41.9%$189.59M+30.0%$174.33M+23.2%$144.75M+8.4%$158.18M+86.2%
$120.5M+5.3%$119.51M+7.8%$117.93M+7.0%$115.96M+9.4%$114.39M+12.1%
$153.8M+32.7%$152.54M+38.2%$123.84M+13.2%$122.62M+18.7%$115.92M+17.2%
$498.73M+28.4%$461.64M+25.8%$416.1M+15.3%$383.33M+11.8%$388.49M+35.9%
$189.52M-2.8%$208.47M+9.2%$225.64M+28.7%$221.86M+24.6%$195.04M-4.2%
21.1%-5.1pp24%-2.7pp27.3%+1.6pp28.7%+1.6pp26.2%-6.8pp
$14.05M-16.4%$14.65M-16.3%$15.31M-15.3%$16.04M-22.7%$16.8M-25.5%
-$531K-$680K
$197.57M+0.2%$215.06M+12.1%$230.46M+31.4%$225.14M+36.4%$197.2M+5.2%
$51.96M+16.8%$56.38M+21.7%$44.78M-15.0%$44.24M-11.5%$44.48M-10.5%
$145.62M-4.7%$158.69M+9.1%$185.68M+51.4%$180.9M+57.3%$152.72M+10.9%
16.2%-4.3pp18.3%-2.1pp22.5%+4.5pp23.4%+5.9pp20.5%-1.8pp
$2.49-5.0%$2.72+8.4%$3.18+50.7%$3.10+59.0%$2.62+13.4%
$213.38M-2.6%$232.33M+8.1%$249.51M+25.0%$245.73M+21.3%$218.99M-4.0%
23.7%-5.7pp26.8%-3.3pp30.2%+0.9pp31.8%+0.9pp29.4%-7.5pp
$189.52M-2.8%$208.47M+9.2%$225.64M+28.7%$221.86M+24.6%$195.04M-4.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Harmony Biosciences Holdings, Inc.'s profit margins?
Gross margin is 76.5% and operating margin is 21.1%, with a 16.2% net margin.
Where does Harmony Biosciences Holdings, Inc.'s income statement data come from?
Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.